Skip Nav Destination
Engineering Health: How Biotechnology Changed Medicine
Edited by
Lara Marks
Lara Marks
Visiting fellow, University College London, UK and Managing editor WhatIsBiotechnology.org
Search for other works by this author on:
Paperback ISBN:
978-1-78262-084-6
PDF ISBN:
978-1-83916-832-1
EPUB ISBN:
978-1-78801-234-8
Special Collection:
RSC Popular Science eBook Collection
Product Type:
Popular Science
No. of Pages:
268
Publication date:
25 Oct 2017
Book Chapter
Chapter 4: Monoclonal Antibodies: A Revolution in the Transformation of Healthcare1
By
Lara V. Marks
Lara V. Marks
Search for other works by this author on:
-
Published:25 Oct 2017
-
Special Collection: RSC Popular Science eBook CollectionProduct Type: Popular Science
Page range:
72 - 96
Citation
L. V. Marks, in Engineering Health: How Biotechnology Changed Medicine, ed. L. Marks, The Royal Society of Chemistry, 2017, ch. 4, pp. 72-96.
Download citation file:
Six out of ten of the top-selling drugs today are monoclonal antibodies (Mabs). This chapter outlines what Mabs are, where they came from and how they are used in medicine. Often overshadowed by other biotechnological tools, such as genetic engineering, Mabs are intrinsic components of everyday healthcare. Not only are they used for drugs, they are a critical tool in the laboratory for investigating the pathology of disease and a major component of a wide variety of diagnostics.
You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
